Travere Therapeutics (TVTX.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec4

Panagora Increases Stake in Travere

11:53

Nov19

Travere Therapeutics Reports Positive Clinical Data and Forecasts Revenue Growth

10:58

Nov17

Travere Therapeutics Updates Strategic Priorities and FILSPARI Drug Progress

04:11

Nov13

HC Wainwright analyst upgrades Travere Therapeutics EPS forecast

15:02

Nov10

JPMorgan Maintains Buy Rating on Travere Therapeutics

02:11

Nov7

H.C. Wainwright Reiterates Buy Rating on Travere Therapeutics with Price Target of $47

12:17

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 164.86 M, Net Income 25.71 M, EPS 0.2754

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 114.45 M, Net Income -12.76 M, EPS -0.1434

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 81.73 M, Net Income -41.23 M, EPS -0.4665

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More